Clinical trial
Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced…
NCT00006786 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00006786 |
|---|---|
| Title | Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer |
| Official title | Phase II Trial of Fluorouracil (5-FU), Leucovorin (LV), Irinotecan (CPT-11) and Bevacizumab (Anti-VEGF) in Previously Untreated Patients With Advanced Colorectal Cancer |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological, Drug |
| Interventions | bevacizumab, fluorouracil, irinotecan hydrochloride, leucovorin calcium |
| Start date | Nov 1, 2000 |
| Completion | Sep 1, 2006 |
| First posted | Feb 12, 2004 |
| Last update posted | Jun 24, 2013 |
| Countries | Puerto Rico, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: